Le Lézard
Classified in: Health, Science and technology, Business
Subject: CCA

Apollo Medical Holdings, Inc. Schedules 2022 Fourth Quarter and Year-end Financial Results Release and Conference Call

ALHAMBRA, Calif., Feb. 9, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that it will release financial results for the fourth quarter and year ended December 31, 2022, after the close of the stock market on Thursday, February 23, 2023. The Company will discuss those results in a conference call at 5:30 a.m. PT/8:30 a.m. ET on Friday, February 24, 2023.

Participant Dial-in Numbers
U.S. & Canada (Toll-Free):        (877) 858-9810
International (Toll):                    (201) 689-8517

To access the call, please dial in approximately five minutes before start time. An accompanying slide presentation will be available in PDF format on the "IR Calendar" page of the Company's website (https://www.apollomed.net/investors/news-events/ir-calendar) after issuance of the earnings release.

The call will also be available via online webcast at:

Those who are unable to attend the live conference call may access the recording at the above webcast link, which will be made available shortly after the conclusion of the call.

About Apollo Medical Holdings, Inc.
ApolloMed is a leading physician-centric, technology-powered, risk-bearing healthcare management company. Leveraging its proprietary end-to-end technology solutions, ApolloMed operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver high quality care to patients in a cost-effective manner.

Headquartered in Alhambra, California, ApolloMed's subsidiaries and affiliates include management services organizations (MSOs), affiliated independent practice associations (IPAs), and entities participating in the Centers for Medicare & Medicaid Services Innovation Center (CMMI) innovation models. For more information, please visit www.apollomed.net.


Investor Relations
(626) 943-6491 

Carolyne Sohn, The Equity Group
(408) 538-4577

SOURCE Apollo Medical Holdings, Inc.

These press releases may also interest you

at 03:05
DTS, Inc., a global leader in next-generation audio, imaging and sensing technology and a wholly owned subsidiary of Xperi Inc. , today announced the global launch of DTS AutoStagetm Broadcaster Portal ? giving radio broadcasters access to data on...

at 03:05
PureTech Health plc ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, and Royalty Pharma , the largest buyer of biopharmaceutical royalties and a leading...

at 03:05
Regulatory News: ESI Group (ISIN Code: FR0004110310, Symbol: ESI), the world-renowned simulation and virtual prototyping software provider for the industry, announces a dynamic new brand identity to mark its 50th anniversary. The company's cultural...

at 03:00
Market Logic Software, the global leader for insights management solutions, is today announcing general availability of DeepSightstm, the world's first AI Assistant trained to answer business questions about market research and intelligence. The...

at 03:00
On March 23, the Japan Patent Office (JPO) released a video interview with Ms. Marina Fujiwara, a creator of "Wasted Creation" or seemingly useless products, whose originality is highly regarded both in Japan and abroad. Ms. Marina...

at 02:35
Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including non-alcoholic...

News published on 9 february 2023 at 08:05 and distributed by: